Centers for Disease Control and Prevention. Influenza and Pneumococcal Vaccination Levels among adults aged >=65 years – United States, 1997. MMWR 1998; 47, 38: 797-802.

Centers for Disease Control and Prevention. Update: Influenza Activity –United States and Worlwide, 1998-99 Season, and Composition of the 1999-2000 Influenza Vaccine. MMWR 1999; 48, 18: 374-9

Centers for Disease Control Travel Information. Preventing Influenza Infection Among Travelers. [Online]: [2 pages], 8 February 1999. Available from: URL: http://www.cdc.gov/travel/feb99.htm

Centers for Disease Control and Prevention. Prevention and control of Influenza: Recommendation of the Advisory Committee on Immunization Practice (ACIP). MMWR 2001, 50 (RR-04). Available from: URL: http://www.cdc.gov/mmwr/preview/htm

Dooley M, Goa KL. Adjuvented Influenza Vaccine. Biodrugs 2000; 14(1):61-9.

Dujarric R.La grippe est-elle une maladie à virus filtrant?. Compte Rendus de l’Académie des Sciences, 1918; 167: 606-7.

Hannoun, Cl. La grippe et ses virus. 1995. Que sais-je? Presses Universitaires de France. Paris

De Donato, Granoff D, Minutello M et al. Safety and immonogenicty of MF59-adjuvented influenza vaccine in the elderly. Vaccine 1999; 17 (23-24): 3094-4001.

de Juanes JR, Arrazola MP. Gripe: problemática e inmunización. En: VII Jornadas Internacionales sobre Actualización en Vacunas. Ed JR

de Juanes. Madrid 1999. 83-91. de Juanes JR. Vacunaciones en el adulto. Guía y Recomendaciones Ed. JR de Juanes Pardo. Madrid 2001.

Lasky T, Terracciano G, Magder L, et al. Guillain Barré syndrome and the 1992-93 and 1993-94 influenza vaccines. N Engl J Med 1998, 339: 1797-802.

Minutello M, Senatore F, Cecchinelli G et al: Safety and immunigenicity of an inactivatedsubunit influenza virus vaccine combined with MF59 adjuvant emulsion in ederly subjets, immunized for three consecutive influenza seasons. Vaccine 1999; 17: 99-104

Podda A. A new adjuvanted influenza vaccine. En: Actualización en vacunas, 2001. Ed. JR de Juanes. Madrid 2001; 143-4.

Rodríguez-Torres A, Castrodeza J, Ortiz de Lejarazu R. Vacuna antigripal. En: Vacunaciones preventivas. Ed L Salleras. Barcelona 1998. 229-57.

Saliou P. Les prespectives d’évolution du vaccin grippal. Groupe d’Etude et d’Information sur la Grippe (GEIG). Livre scientifique. Biarritz. Francia 1998.

WHO. Influenza Pandemic Preparedness Plan. The role of WHO and Guidelines for National and Regional Planning. Geneva 1999. Available from: URL: http://www.who.int/emc-documents/influenza

- Wood JM. Influenza vaccine strains for the 2001-2002 season. ESWI 2001, 13. 2

José Ramòn de Juanes- BIBLIOGRAFIA/REFERENCES